Request Deal Involvement
Aerami Therapeutics terminated its merger with FoxWayne Enterprises Acquisition in a $250m deal.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
SternAegis Ventures
legal advisors
Smith Anderson
pr advisors
Core IR
legal advisors
Sheppard Mullin Richter & Hampton
or
Principals
target
AERAMI THERAPEUTICS
bidder
FOXWAYNE ENTERPRISES ACQUISITION
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite